Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2008 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
2019 Standout
Cardiac Toxicity Following Thoracic Radiation
2005
Quality of life, health care utilization, and costs among women undergoing hysterectomy in a managed-care setting
1998
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer
2003 Standout
Hepatocellular carcinoma
2016 Standout
A randomized trial comparing adjuvant chemotherapy versus surgery alone for completely resected pN2 non-small cell lung cancer (JCOG9304)
2004
Guidelines on the radical management of patients with lung cancer
2010
The biology and management of non-small cell lung cancer
2018 StandoutNature
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
2009 Standout
Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial
1999
Treatment of Non-small Cell Lung Cancer-Stage IIIA
2007
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study
2008 Standout
Prognostic factors in non-small cell lung cancer surgery
2005
Multimodal strategies to improve surgical outcome
2002 Standout
Lung cancer: New biological insights and recent therapeutic advances
2011
Contribution of Primary Care to Health Systems and Health
2005 Standout
Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial
1999
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
2017 Standout
Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour
2006 Standout
The role of chemotherapy in early stage of non-small cell lung cancer
2001
Lung cancer: current therapies and new targeted treatments
2016 Standout
Ten-year survey of lung cancer treatment and survival in hospitals in the United States
1999
Investigating patient exclusion bias in meta-analysis
2004
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Human papillomavirus and cervical cancer
2007 Standout
Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: Results of a meta-analysis of the literature
2005
Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study
2003
Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves
2012 Standout
Systematic Review and Meta-analysis
2008 Standout
Treatment of Stage I and II Non-small Cell Lung Cancer
2013
Meta-analysis when only the median survival times are known: A comparison with individual patient data results
2005
Early-Stage Non–Small-Cell Lung Cancer: Current Perspectives in Combined-Modality Therapy
2004
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Non-small-cell lung cancer
2015
PEGylation, successful approach to drug delivery
2005 Standout
Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes
2004
Gene-expression profiles predict survival of patients with lung adenocarcinoma
2002 Standout
CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials
2011 Standout
Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review
2007
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Subgroup analysis in randomised controlled trials: importance, indications, and interpretation
2005
Practical methods for incorporating summary time-to-event data into meta-analysis
2007 Standout
Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial
2012 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
A Randomized Trial of Postoperative Adjuvant Therapy in Patients with Completely Resected Stage II or IIIa Non–Small-Cell Lung Cancer
2000
Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix
2005
Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS®) Society and the European Society of Thoracic Surgeons (ESTS)
2018 Standout
From radiotherapy to Targeted therapy: 20 years in the management of non-small-cell lung cancer.
2006
Meta-analysis of individual patient data from randomized trials: a review of methods used in practice
2005
Neoadjuvant Chemotherapy in Invasive Bladder Cancer: Update of a Systematic Review and Meta-Analysis of Individual Patient Data
2005 Standout
A randomized phase III trial of adjuvant chemotherapy with UFT for completely resected pathological stage I non-small-cell lung cancer: the West Japan Study Group for Lung Cancer Surgery (WJSG)—the 4th study
2004
Role of Postoperative Radiotherapy in Resected Non-Small Cell Lung Cancer: A Reassessment Based on New Data
2011
Artificial intelligence in cancer imaging: Clinical challenges and applications
2019 Standout
Adjuvant MAGE-A3 Immunotherapy in Resected Non–Small-Cell Lung Cancer: Phase II Randomized Study Results
2013
Diagnosis and Management of Cerebral Venous Thrombosis
2011 Standout
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
2008 Standout
Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non–Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update
2017
Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung Cancer
2004 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
To IPD or not to IPD?
2002
Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data
2010
Postoperative radiotherapy for non-small cell lung cancer
2016
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
2010 Standout
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Guidelines on the selection of patients with lung cancer for surgery
2001
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Works of Kovač being referenced
Hysterectomy. A comparative statistical study of abdominal vs. vaginal approaches.
1988
Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials
1998